Mesoblast Limited(NASDAQ:MESO) 
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine...
Website: http://www.mesoblast.com
Founded: 2004
Full Time Employees: 102
CEO: Silviu Itescu
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 11.06
H 11.15
L 10.35
C 10.57
V 344,948
10EMA 10.57
20EMA 10.57
60EMA 10.57
120EMA 10.57
250EMA 10.57